CONNECT WITH US:
Jun, 12 2019 15:00 JST
Singapore eDevelopment Ltd
Global BioLife's 3F Mosquito Repellent Formula performs well in Independent Testing
SINGAPORE, Jun, 12 2019 - (ACN Newswire) - SGX-listed Singapore eDevelopment Ltd (SeD) wishes to announce that U.S. biomedical subsidiary Global BioLife Inc. has independently tested its new 3F Mosquito Formula which performs well against mosquitoes for six (6) to eight (8) hours.
In 2017, SeD announced a collaboration between Global BioLife and U.S. based Chemia Corporation to develop a suite of fragrances referred to as 3F (Functional Fragrance Formulation). Previous testing was promising for the 3F Mosquito Fragrance, which is made of specialised oils sourced from botanicals that mosquitoes avoid in varying concentrations of 0.25% to 5%.
Global BioLife contracted U.S. based Snell Scientifics, LLC in Meansville, Georgia to conduct a study on the new mosquito repellent formula and the results of the study showed that it repelled between 82% to 95% of mosquitos for six (6) hours after application.
"Utilising fragrances to repel mosquitos with this level of efficacy is a game changer for the consumer products industry," said Mr. Thomas A. Meyer, Chemia's Vice-President of Innovation and Sustainability.
Globally, an estimated 3.4 billion people in 92 countries are at risk of being infected with Zika, Dengue, West Nile Virus, Malaria and other mosquito transmitted diseases. Mosquito repellent products are key in the fight against mosquito transmitted diseases, while a product favoured by consumers is easy to apply, is considered safe, and does not have unpleasant attributes such as a strong chemical odour.
The market for safe mosquito repellents is expanding, and consumers have expressed a demand for effective mosquito repellent products with appealing scents. The most recently tested product has a fragrance that is modeled on the fresh scent of the Ghost Orchid, a rare flower known for its distinctive and pleasant aroma found in the Everglades of Florida.
"3F Mosquito works differently from traditional insect repellents. It's effective even at very low concentrations due to its multi-aspect receptor inhibition," said Mr. Daryl Thompson, Global BioLife's Director of Scientific Initiatives.
"Global BioLife is extremely proud of these test results," said SeD's Executive Chairman Mr. Chan Heng Fai. "3F is an innovative product that works in an entirely different manner from any other product on the market today. 3F is a true success for people everywhere and will help reduce the number of mosquito transmitted diseases on a global scale."
Global BioLife is currently in discussions with interested companies for potential licensing and global deployment of this new mosquito repellent formula.
About Singapore eDevelopment Limited
Incorporated on 9 September 2009 and listed on the Singapore Exchange in July 2010, Singapore eDevelopment Limited is involved in (i) property development and investments primarily in the United States and Western Australia; (ii) information technology-related businesses; (iii) development, research, testing, manufacturing, licensing and distribution of biomedical products; and (iv) investment activities. For more information, please visit: www.SeD.com.sg or email
About Global BioLife Inc.
Global BioLife Inc. ("GBLI") is a 70%-held direct subsidiary of Global BioMedical Inc., which is a wholly-owned direct subsidiary of Singapore BioMedical Pte. Ltd., which in turn is a wholly-owned direct subsidiary of Singapore eDevelopment Limited, a company listed on the Singapore Exchange. The remaining shareholding of Global BioLife Inc. is held by Global Research and Discovery Group Scientific LLC ("GRDGS") at 20% and Australian Exchange-listed Holista CollTech Limited ("Holista") at 10%. For more information, please visit:
About GRDG Sciences, LLC.
GRDG Sciences, LLC is an advanced research team formed in Florida by natural products discovery drug research scientist, Daryl Thompson. For more information, please visit:
Source: Singapore eDevelopment Ltd
Sectors: HealthCare, Cosmetics/Spec.Chem
Copyright ©2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Sysmex Presents Academic Report with a View to Creating a Simple Method of Diagnosing Alzheimer's Disease Using Blood
Dec 09, 2019 09:36 JST
Eisai Satisfies All-Case Surveillance Condition for Approval of Anti-Cancer Agent Lenvima in Treatment of Thyroid Cancer
Dec 09, 2019 09:17 JST
TOYOTA GAZOO Racing Back in Bahrain
Dec 06, 2019 21:10 JST
Hitachi to Provide CNAO with Proton Therapy System
Dec 06, 2019 19:16 JST
First Trenitalia Chooses Hitachi Rail to Build New Intercity Trains for Avanti West Coast
Dec 06, 2019 19:02 JST
Fujitsu Launches SAP Solution to Support Mass Customization in Engineer-to-Order Production
Dec 06, 2019 18:20 JST
DOCOMO and Kyoto University Develop World's First AI System to Detect Bridge Deterioration using Video-based Vehicle Weights and Structural Deflection
Dec 05, 2019 14:17 JST
Fujitsu Successfully Grows Diamond Film to Boost Heat Dissipation Efficiency of GaN HEMT
Dec 05, 2019 13:06 JST
KMD buys IT System for Disaster Assistance from Plass Data
Dec 05, 2019 12:31 JST
Fujitsu Takes Key Step Toward Implementing SAP S/4HANA Manufacturing for Production Engineering and Operations to Streamline Aircraft Production at Kawasaki Heavy Industries
Dec 05, 2019 11:11 JST
Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium
Dec 05, 2019 09:11 JST
Mitsubishi Corporation: Dedicated Biomass Power Generation at Suzukawa Energy Center
Dec 04, 2019 16:35 JST
Panasonic and Toyota Confirm Location and Executive Structure of Town Development Joint Venture
Dec 04, 2019 15:32 JST
Mitsubishi Corporation Establishes New Tech Subsidiary, MC Digital
Dec 03, 2019 16:49 JST
MHI Thermal Systems Wins 22nd "Environment Minister's Award for Global Warming Prevention Activity" for its High-efficiency Next-generation ETI-Z Series Centrifugal Chillers
Dec 03, 2019 15:08 JST
Hitachi: Power Grid Protection System Starts its Demonstration Operation in Poland
Dec 03, 2019 12:31 JST
MHPS to Exhibit at the Japan Pavilion at COP25 in Madrid, Spain from December 2
Dec 02, 2019 16:32 JST
Fujitsu Begins Shipping Supercomputer Fugaku
Dec 02, 2019 13:23 JST
Mitsubishi Heavy Industries Asia Pacific Establishes Yangon Representative Office
Dec 02, 2019 12:57 JST
Eisai to Present Latest Data on Alzheimer's Disease / Dementia Pipeline at 12th Clinical Trials on Alzheimer's Disease Conference
Dec 02, 2019 09:23 JST
More Latest Release >>
Global BioLife to Present 3F Antimicrobial Fragrance at 2020 ASM Biothreats
November 15 2019 02:00 JST
Global BioLife to present Functional Fragrance Formula at the American Society for Microbiology's Biothreats Conference as a New Method to Prevent and Treat Tuberculosis
October 29 2019 09:00 JST
Global BioLife unveils naturally modified Laetose at Harvard Global Catalyst Health Summit
July 24 2019 15:00 JST
Global BioLife's 3F Antimicrobial Fragrance shows Efficacy against Tuberculosis
January 28 2019 12:00 JST
Singapore eDevelopment's Global BioLife to present Parkinson's Research at Neuroscience 2018
November 07 2018 19:00 JST
Singapore eDevelopment Limited Announces Corporate and Business Update
June 18 2018 19:00 JST
Singapore eDevelopment's Global BioLife develops Low Glycemic Modified Sugar
May 31 2018 18:00 JST
Singapore eDevelopment's Global BioLife confirms LB2 efficacy against Ebola
March 01 2018 14:00 JST
Singapore eDevelopment's Global BioLife confirms 100% Repellency of 3F Mosquito Fragrance
November 01 2017 18:00 JST
Singapore eDevelopment's Global BioLife develops Low-GI Modified Sugar
October 24 2017 18:00 JST
More Press release >>